TLSI

TriSalus Life Sciences, Inc. (TLSI) 10Y Growth Potential Analysis (2026)

Invetso Score: 2.8/10 — Weak · Last Updated: 2026-08-01

Overall Score

Business Quality

Gross margin is very strong at 85.8%, but operating margin remains deeply negative at -67.7% and net margin at -62.6%.

Asset turnover is decent at 0.72x and fixed asset turnover is high at 17.1x, indicating some operating efficiency.

The business still shows poor capital efficiency with ROIC at -59.2% and ROCE at -59.5%.

Financial Strength

Liquidity is strong with a current ratio of 5.35x, quick ratio of 4.97x, and cash ratio of 4.14x.

Net debt to EBITDA is modest at 0.55x, but leverage remains elevated with debt to equity at 5.26x and financial leverage at 9.53x.

Interest coverage is negative at -5.23x, reflecting weak earnings support for debt service despite the balance-sheet liquidity.

Growth Trend

Revenue per share is only 0.77, while profitability remains negative across EBIT, pretax, and net income margins.

Working capital is positive at 48.6M, but the cash conversion cycle is still long at 77.5 days.

There is no evidence in the current data of durable earnings growth or improving profitability.

Valuation

Valuation remains demanding at 6.60x price-to-sales and 42.99x price-to-book despite negative earnings and cash flow.

EV to sales is 6.33x, while EV to EBITDA and EV to free cash flow are both negative because EBITDA and FCF are negative.

Negative earnings yield and free cash flow yield indicate the stock is not supported by current fundamentals.

Momentum

No recent news was provided to support a positive momentum shift.

The latest TTM data still show negative operating performance and negative free cash flow.

Without evidence of improving earnings or guidance, momentum remains weak.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on TriSalus Life Sciences, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →